223 related articles for article (PubMed ID: 25220592)
21. Comprehensive profiling of 8p11-12 amplification in breast cancer.
Gelsi-Boyer V; Orsetti B; Cervera N; Finetti P; Sircoulomb F; Rougé C; Lasorsa L; Letessier A; Ginestier C; Monville F; Esteyriès S; Adélaïde J; Esterni B; Henry C; Ethier SP; Bibeau F; Mozziconacci MJ; Charafe-Jauffret E; Jacquemier J; Bertucci F; Birnbaum D; Theillet C; Chaffanet M
Mol Cancer Res; 2005 Dec; 3(12):655-67. PubMed ID: 16380503
[TBL] [Abstract][Full Text] [Related]
22. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
Moffa AB; Tannheimer SL; Ethier SP
Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
[TBL] [Abstract][Full Text] [Related]
23. KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs.
Yan F; Li J; Milosevic J; Petroni R; Liu S; Shi Z; Yuan S; Reynaga JM; Qi Y; Rico J; Yu S; Liu Y; Rokudai S; Palmisiano N; Meyer SE; Sung PJ; Wan L; Lan F; Garcia BA; Stanger BZ; Sykes DB; Blanco MA
Cancer Discov; 2022 Mar; 12(3):792-811. PubMed ID: 34853079
[TBL] [Abstract][Full Text] [Related]
24. Genetic alterations and oncogenic pathways associated with breast cancer subtypes.
Hu X; Stern HM; Ge L; O'Brien C; Haydu L; Honchell CD; Haverty PM; Peters BA; Wu TD; Amler LC; Chant J; Stokoe D; Lackner MR; Cavet G
Mol Cancer Res; 2009 Apr; 7(4):511-22. PubMed ID: 19372580
[TBL] [Abstract][Full Text] [Related]
25. Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.
Lombardo Y; Filipović A; Molyneux G; Periyasamy M; Giamas G; Hu Y; Trivedi PS; Wang J; Yagüe E; Michel L; Coombes RC
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16558-63. PubMed ID: 23012411
[TBL] [Abstract][Full Text] [Related]
26. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
27. Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma.
Haery L; Mussakhan S; Waxman DJ; Gilmore TD
Leuk Lymphoma; 2016 Nov; 57(11):2661-71. PubMed ID: 27003102
[TBL] [Abstract][Full Text] [Related]
28. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
29. Matrix stiffness-induced upregulation of histone acetyltransferase KAT6A promotes hepatocellular carcinoma progression through regulating SOX2 expression.
Zhao W; Mo H; Liu R; Chen T; Yang N; Liu Z
Br J Cancer; 2022 Jul; 127(2):202-210. PubMed ID: 35332266
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Bernard-Pierrot I; Gruel N; Stransky N; Vincent-Salomon A; Reyal F; Raynal V; Vallot C; Pierron G; Radvanyi F; Delattre O
Cancer Res; 2008 Sep; 68(17):7165-75. PubMed ID: 18757432
[TBL] [Abstract][Full Text] [Related]
31. Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.
Yu L; Liang Y; Cao X; Wang X; Gao H; Lin SY; Schiff R; Wang XS; Li K
Oncogene; 2017 May; 36(20):2910-2918. PubMed ID: 27893709
[TBL] [Abstract][Full Text] [Related]
32. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
[TBL] [Abstract][Full Text] [Related]
33. RNA interference-based functional dissection of the 17q12 amplicon in breast cancer reveals contribution of coamplified genes.
Kao J; Pollack JR
Genes Chromosomes Cancer; 2006 Aug; 45(8):761-9. PubMed ID: 16708353
[TBL] [Abstract][Full Text] [Related]
34. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
35. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Cornen S; Guille A; Adélaïde J; Addou-Klouche L; Finetti P; Saade MR; Manai M; Carbuccia N; Bekhouche I; Letessier A; Raynaud S; Charafe-Jauffret E; Jacquemier J; Spicuglia S; de The H; Viens P; Bertucci F; Birnbaum D; Chaffanet M
PLoS One; 2014; 9(1):e81843. PubMed ID: 24416132
[TBL] [Abstract][Full Text] [Related]
36. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology.
Wiesel-Motiuk N; Assaraf YG
Drug Resist Updat; 2020 Dec; 53():100729. PubMed ID: 33130515
[TBL] [Abstract][Full Text] [Related]
37. A co-culture genome-wide RNAi screen with mammary epithelial cells reveals transmembrane signals required for growth and differentiation.
Burleigh A; McKinney S; Brimhall J; Yap D; Eirew P; Poon S; Ng V; Wan A; Prentice L; Annab L; Barrett JC; Caldas C; Eaves C; Aparicio S
Breast Cancer Res; 2015 Jan; 17():4. PubMed ID: 25572802
[TBL] [Abstract][Full Text] [Related]
38. [ZNF703: a novel oncogene involved in breast cancer].
Ginestier C; Sircoulomb F; Charafe-Jauffret E; Chaffanet M; Birnbaum D
Med Sci (Paris); 2011 Apr; 27(4):357-9. PubMed ID: 21524397
[No Abstract] [Full Text] [Related]
39. Comparison between karyotyping-FISH-reverse transcription PCR and RNA-sequencing-fusion gene identification programs in the detection of KAT6A-CREBBP in acute myeloid leukemia.
Panagopoulos I; Torkildsen S; Gorunova L; Tierens A; Tjønnfjord GE; Heim S
PLoS One; 2014; 9(5):e96570. PubMed ID: 24798186
[TBL] [Abstract][Full Text] [Related]
40. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes.
Guest ST; Kratche ZR; Bollig-Fischer A; Haddad R; Ethier SP
Exp Cell Res; 2015 Mar; 332(2):223-35. PubMed ID: 25704758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
